Loading
No insider purchase over the last 90 days. The latest was filed 19 Feb 2026.
SelectQuote, Inc.: what insiders have been doing
Every trade that managers of SelectQuote, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Banks sector. From 18 October 2025 to 18 October 2026, the disclosure feed for SelectQuote, Inc. logged 57 filings by 15 insiders.
Both sides are active: 1 purchase worth €29k and 1 sale worth €3,515, from 1 insider and 1 insider respectively. Netting one side against the other leaves €26k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €29k, the purchase published on 19 February 2026 by Grant Robert Clay is the largest of the period (0.025% of market cap). The buyers include 1 chief executive.
The clock since the last published purchase (19 February 2026) now reads 241 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction.
With 57 filings in twelve months, the company is more active than the median of 19 filings across the 5,810 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 23 purchases and 1 sale. In its latest annual report filed with the SEC (10-K, fiscal year ended 30 June 2026), the company reported revenue of 1.62 bn USD and net income of 62.2 m USD.
For comparison within the same sector, see the insider buying recorded at First Guaranty Bancshares, Inc. and BCB Bancorp Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
191
Thresholds
n/a
Buy Volume
€8M
23 ops. · all time
Sell Volume
€3,515
1 ops. · all time
Who traded when
BuySaleDenise L. Devine1 buy1 sale
Robert Clay Grant1 buy
Since the insiders bought
- +19.1%Entry US$0.89 · Close at T+90 US$1.06
- -84.4%Entry US$3.81 · Close at T+365 US$0.60
- +63.1%Entry US$1.22 · Close at T+365 US$1.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,713 of 24,148 companies
72.7
score / 100
Value96
Quality50
FCF yld26%
Earn yld·
EV/EBITDA3.3x
ROE10%
Gross mgn36%
Net mgn3.8%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
US$0.34
Analyst consensus
4 analysts2.00/5
US$0.50Target US$2.13(+525%)US$3.00
Income statement
RevenueUS$1.6B
Gross profitUS$575.6M36% margin
EBITDAUS$138.3M9% margin
Net incomeUS$62.2M3.8% margin
Valuation
PER (forward)17.0x
P/Book0.2x
Beta1.94
Balance sheet & cash
Market capUS$60.9M
Total debtUS$396.4M
Free Cash FlowUS$15.7M
Debt / Equity61%
Profitability & ownership
ROE10.1%
ROA3.6%
% insiders9.7%
% institutions46.0%
Last declaration on 4 August 2026
Declarations191 total
279,583 shares@ US$0.7470.29% mcap15.6% of flowCommon Stock, par value $0.01 per shareSEC:0001794783-26-000045:5
57,779 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000044:0
25,568 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000047:0
14,561 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000047:1
37,143 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000047:2
3,196 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000047:3
4,854 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000047:4
88,889 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000041:0
45,261 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000041:1
56,666 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000041:2
11,111 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000041:3
15,087 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000041:4
88,889 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000048:0
63,897 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000048:1
90,000 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000048:2
11,111 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000048:3
21,299 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000048:4
266,668 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000045:0
127,795 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000045:1
160,000 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000045:2
33,333 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000045:3
42,598 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000045:4
17,515 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000046:0
9,518 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000046:1
24,788 shares0Common Stock, par value $0.01 per shareSEC:0001794783-26-000046:2
25 of 191 declarations
About SelectQuote, Inc.
SelectQuote, Inc. (ticker: SLQT) is a United States-based public company listed on the NYSE/NASDAQ, with headquarters in Overland Park, Kansas, United States. Founded in 1985, the company built its brand as a pioneer in direct-to-consumer insurance shopping, initially by offering unbiased price comparisons across multiple highly rated life insurance carriers. That origin still defines the investment case today: SelectQuote is primarily a distribution and advisory platform, not a balance-sheet insurer. Its value proposition lies in licensed-agent expertise, proprietary lead-generation and routing technology, and a consultative sales model that aims to simplify complex insurance decisions for consumers.
SelectQuote has evolved from a single-product life insurance agency into a broader healthcare and insurance ecosystem. Its core business lines currently include SelectQuote Senior, which focuses on Medicare-related products; SelectQuote Life, which serves life insurance shoppers; and SelectQuote Healthcare Services, which extends the relationship beyond insurance distribution into health services and care navigation. In earlier disclosures, the company also highlighted Auto & Home as an additional consumer-facing line. Strategically, this mix allows SelectQuote to deepen customer engagement across insurance, pharmacy, and value-based care touchpoints, increasing the opportunity to monetize consumers beyond the initial quote and enrollment process.
Read moreShow less
From a competitive standpoint, SelectQuote operates in a fragmented but crowded market that includes independent agencies, digital comparison platforms, carrier-direct channels, and benefits brokers. Its differentiators are its long operating history, national scale, and the combination of human advice with technology-enabled lead sourcing. Management has repeatedly emphasized the company’s consultative model and the breadth of carrier relationships, which are central to its positioning as a shopping solution rather than a single-carrier sales outlet. The company says it serves consumers across all 50 U.S. states and has additional offices beyond Kansas, including locations in California, Colorado, Florida, and Iowa.
Recent corporate developments have been important for the equity story. In 2025, SelectQuote closed a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners, using part of the proceeds to reduce debt and strengthen liquidity. In 2026, the company announced a new $415 million credit facility, further reinforcing the balance sheet. These financing actions suggest a continued focus on refinancing flexibility and support for the company’s insurance distribution and expanding healthcare services platform. For investors, SLQT remains a transformation story tied to execution in Medicare distribution, customer acquisition economics, and the scalability of its healthcare services initiatives.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
